
flanders.bio has merged with @MEDVIA_be to become Biovia. This account will no longer be updated. Please follow us on LinkedIn. ➡️linkedin.com/company/biovia-…

flanders.bio & MEDVIA have merged and become Biovia. This account is no longer active. Please follow us on LinkedIn: linkedin.com/company/biovia-…

flanders.bio has merged with @MEDVIA_be to become Biovia. This account will no longer be updated. Please follow us on LinkedIn. ➡️linkedin.com/company/biovia-…

At the upcoming shareholders’ meeting, @biotalys will be appointing Toni Bucci as independent director to its Board of Directors. 👩🏽🔬 flanders.bio/news/biotalys-a…

Augustine Therapeutics successfully completed its Series A financing round, raising a total of EUR 77.7 million. The proceeds will be used to advance Augustine’s lead candidate, AGT-100216. 🔗 flanders.bio/news/augustine-…

By reprogramming the metabolism of T cells, scientists at the @vib_ccb and their collaborators demonstrated a remarkable ability to boost the immune system's fight against cancer. 🦠 flanders.bio/news/reprogramm…

New research, led by researchers at the @VIBLifeSciences-@ugent Center for Plant Systems Biology, provides a comprehensive understanding of how #brassinosteroids influence development at the cellular level. 🌿 flanders.bio/news/new-insigh…

Field trials with one of @biotalys’ lead candidates for #BioFun6 highlight the increased potency of the new candidate against #Botrytis and #PowderyMildew in fruits and vegetables. 🍇 flanders.bio/news/biotalys-a…

Positive interim results in @Agomab_’s ongoing #STENOVA Phase 2a clinical trial for the potential treatment of Fibrostenosing Crohn’s Disease (#FSCD)! 🔬 flanders.bio/news/agomab-ann…

4Tissue has completed a €1.5M funding round to advance its bioresorbable #hydrogel technology. The company is also excited to welcome Dr. Katleen Verleysen as independent chair of the board. 🚀flanders.bio/news/4tissue-se…

Big news for #RRP patients! @Precigen’s biologics license application (#BLA) for PRGN-2012, a groundbreaking AdenoVerse® #genetherapy, has been accepted by the FDA. With priority review granted, the FDA has set a target action date of Aug 27, 2025. 🫁 flanders.bio/news/fda-grants…

Prof. Stein Aerts and his team at VIB.AI and @CBD_VIB explored how genetic switches, controlling gene activity, define brain cell types across species. Their study was published in Science. 🔗 flanders.bio/news/scientists…

Augustine Therapeutics has appointed Gerhard Koenig, PhD, as Chief Executive Officer. 🔗 flanders.bio/news/augustine-…

Allegro Biotech has been awarded the prestigious #CompanionAnimalsPrize at the #AnimalHealthEurope2025 Conference in London. 🏆 🔗 flanders.bio/news/allegro-wi…

📆 Don’t miss Knowledge for Growth on 8 May, where we will unveil the name of our new, unified organization, provide an update on the structure and goals and commence with appropriate celebrations! 🍾 𝗠𝗼𝗿𝗲 𝗼𝗻 𝘁𝗵𝗲 𝗺𝗲𝗿𝗴𝗲𝗿 𝗵𝗲𝗿𝗲 👉 flanders.bio/news/medvia-and…

⛙ Over the next few days and months, we will further finalize this powerful merger to officially create one, new organization. 🔥 With a united voice, we will represent the entire #biotech and #healthtech ecosystem on the regional, federal and European stage. How cool is that?

✅ Yesterday our members voted in favor of a merger with @MEDVIA_be — an overwhelming 98% approval from 124 present or represented effective members! This follows the 96% majority vote among MEDVIA’s members in January.

🚨 Early bird registration for #KfG2025 closes 15 Feb 2025, 23:59 CEST! Join our top life sciences event to connect, learn, and discover the future of #biotech, #pharma, #medtech & #healthtech 🌱 💸 Don’t miss the best rate — register now 👉 knowledgeforgrowth.be/ #lifesciences